Download PDF
Thromb Haemost 2000; 84(02): 351-352
DOI: 10.1055/s-0037-1614020
Letters to the Editor
Schattauer GmbH

Pregnancy in Women with Type 1 von Willebrand Disease Caused by Heterozygosity for von Willebrand Factor Mutation C1130F

Giancarlo Castaman
2   From the Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
,
Jeroen C. J. Eikenboom
1   Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands
,
Antonella Contri
2   From the Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
,
Francesco Rodeghiero
2   From the Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy
› Author Affiliations
Further Information

Publication History

Received 19 April 2000

Accepted 20 April 2000

Publication Date:
14 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Kouides PA. Females with von Willebrand disease: 72 years as the silent majority. Haemophilia 1998; 04: 665-76.
    CrossrefPubMedGoogle Scholar
  • 2 Castaman G, Eikenboom JCJ, Missiaglia E, Rodeghiero F. Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect. Br I Haematol 2000; 108: 876-9.
    PubMedGoogle Scholar
  • 3 Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68: 282-5.
    PubMedGoogle Scholar
  • 4 Greer IA, Lowe GD, Walker II, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br I Obstet Gynaecol 1991; 98: 909-18.
    PubMedGoogle Scholar
  • 5 Ramsahoye BH, Davies SV, Dasani H, Pearson IF. Obstetric management in von Willebrand’s disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 01: 140-4.
    CrossrefPubMedGoogle Scholar
  • 6 Castaman G, Rodeghiero F. Cunrent management of von Willebrand’s disease. Drugs 1995; 50: 602-12.
    CrossrefPubMedGoogle Scholar
  • 7 Rodeghiero F, Castaman G, Di Bona E, Ruggeri M, Lombardi R, Mannucci PM. Hyper-responsiveness to DDAVP for patients with type I von Willebrand’s disease and normal intra-platelet von Willebrand factor. Eur I Haematol 1988; 40: 163-6.
    PubMedGoogle Scholar